바로가기메뉴

본문 바로가기 주메뉴 바로가기

Diagnostic efficiency and differential ability of MMPI-2 and Rorschach: Focus on Schizophrenia-Spectrum Disorder

The Korean Journal of Health Psychology / The Korean Journal of Health Psychology, (P)1229-070X; (E)2713-9581
2016, v.21 no.2, pp.411-430
https://doi.org/10.17315/kjhp.2016.21.2.007


  • Downloaded
  • Viewed

Abstract

In this study, we compared the MMPI-2 and Rorschach tests, that are representative assessments in clinical practice including the index of psychotic state; in addition, we investigated the predictive validity and the discriminant validity for psychotic disorder indices of each assessment. Participants were 59 adults who underwent psychological testing at the department of psychiatry of the general hospital in Busan. Patients with schizophrenia, schizophreniform disorder, and brief psychotic disorder were categorized into the group with schizophrenia spectrum disorders; and patients with mood disorder, anxiety disorder, somatoform disorder, and adjustment disorder were categorized into the group with non-schizophrenia spectrum disorders. Logistic regression analysis was conducted using schizophrenia-related indicators from the MMPI (Pa, Sc3, Sc6, BIZ1, BIZ2, RC8, and PSYC) and Rorschach’s test (SCZI and PTI) as variables. The results showed that RC8, BIZ1, and Sc3 had significant between-group discriminatory power; however, neither of the Rorschach variables, SCZI and PTI, showed significant discriminatory power. In conclusion, aberrant perceptual experiences and cognitive distortion are decisive factors in the discrimination of schizophrenia spectrum disorders. The MMPI-2 was developed for schizophrenia patients. However, it includes symptoms such as aberrant perceptual experiences and cognitive distortion, as well as paranoia features that can be experienced by patients both with and without schizophrenia. Our results suggested that this instrument should be used sparingly. Finally, we discussed the limitations of the study, future research directions, and psychological health significance.

keywords
MMPI-2, Rorschach, BIZ1, RC8, Sc3, 정신병, 조현병, MMPI-2, Rorschach, BIZ1, RC8, Sc3 Psychotic feature, Schizophrenia

Reference

1.

고윤화, 손용훈, 윤정홍, 오상우, 이귀행, 박민철 (2008). 정신분열증 환자와 우울증 환자의 MMPI-2 프로파일, 원광의과학, 23(2), 79-86.

2.

김중술, 이한주, 한수정 (2003). 사례로 읽는 임상심리학. 서울 : 서울대학교출판문화원.

3.

김중술, 한경희, 임지영, 이정흠, 민병배, 문경주, (2006). 한국판 MMPI-2 의 개발 연구. 한국심리학회지: 임상, 25(2), 533-564.

4.

김중술, 홍강의, 조수철, 신민섭 (2000). 왜 진단적 심리검사 결과가 일치하지 않는가 : Rorschach와MMPI의 경우. 한국심리학회지: 임상, 19(3), 393-407.

5.

김현호, 한양순, 한일우 (1993). SESSION 8: 심리장애및 진단: 정신분열증환자, 양극성장애환자 및 분열정동장애환자 간의 MMPI 판별 연구. 한국심리학회 연차 학술발표논문집, 1993(단일호), 347-356.

6.

배금예 (2008). 로샤검사에서 SCZI, PTI, EII-2의 진단적유용성과 진단변별력. 경북대학교 박사학위 논문.

7.

보건복지부, 서울대학교 산학협력단(2013). 국가정신건강검진체계 개발연구. 서울: 보건복지부.

8.

설순호, 신민섭. (2012). 조현병과 우울장애의 감별 진단시 다면적 인성검사-Ⅱ (MMPI-2) 내용척도 및 재구성 임상척도의 활용. 한국심리치료학회지, 4(2), 1-15.

9.

유인옥, 박순환, 주영희 (1993). 조증환자와 정신분열증환자의 Rorschach 반응 비교(1). 한국심리학회지:임상, 12(2), 62-72.

10.

유정민, 안소라, 조유선, 이명수 (2011). 초발정신질환자를 대상으로 하는 정신질환 미치료기간에 대한 연구. 정신보건, 2(0), 12-16

11.

육근정, 도진아, 배호순, 임명호 (2010). 외현화, 내재화문제를 가진 아동 임상집단의 Rorschach 반응 특성에 관한 분석연구. 한국심리학회지: 임상, 29(1), 241-258.

12.

원호택, 이훈진 (2000). 정신분열증. 서울 : 학지사.

13.

이우경, 이원혜 (2012). 심리평가의 최신흐름. 서울 : 학지사.

14.

정윤경, 박은희, 전덕인, 석정호, 홍나래 (2009). 임상현장에서 MMPI-2 진단적 유용성: 우울증 환자군과정신분열증 환자군의 비교. 한국심리학회지: 임상, 28(2), 339-362.

15.

최혜라, 김중술 (1996). Rorschach 검사의 Schizophrenia Index 의 진단적 유용성에 관한 연구. 한국심리학회지: 임상, 15(1), 179-184.

16.

한경희, 김중술, 임지영, 이정흠, 민병배, 문경주 (2011). MMPI-2 다면적 인성검사 Ⅱ 매뉴얼 개정판. 서울 :마음사랑.

17.

한오수, 홍진표 (2000). DSM-IV 의 제 1 축 장애의 구조화된 임상적 면담. SCID-I 연구용 판. 서울 : 하나의학사.

18.

American Psychiatric Association. (2000). DSM-Ⅳ-TR. Diagnostic and Statistical Manual of Mental Disorders,(4th Ed. Text Revision ed.). Washington DC: APA.

19.

Archer, R. P., & Krishnamurthy, R. (1993). A review of MMPI and Rorschach interrelationships in adult samples. Journal of Personality Assessment, 61(2), 277-293.

20.

Bannatyne, L. A., Gacono, C. B., & Greene, R. L. (1999). Differential patterns of responding among three groups of chronic, psychotic, forensic outpatients. Journal of clinical psychology, 55(12), 1553-1565.

21.

Ben-Porath, Y. S., Butcher, J. N., & Graham, J. R. (1991). Contribution of the MMPI-2 content scales to the differential diagnosis of schizophrenia and major depression. Psychological Assessment: A Journal of Consulting and Clinical Psychology, 3(4), 634-640.

22.

Butcher, J. N. (2000). Revising psychological tests:Lessons learned from the revision of the MMPI. Psychological assessment, 12(3), 263.

23.

Cámara, W., Nathan, J., & Puente, A. (1998). Psychological test usage in professional psychology: Report of the APA practice and science directorates. Washington, DC: american psychological association.

24.

Dao, T. K., Prevatt, F., & Horne, H. L. (2008). Differentiating psychotic patients from nonpsychotic patients with the MMPI–2 and Rorschach. Journal of personality assessment, 90(1), 93-101.

25.

Exner, JE, Jr. (1974). The Rorschach: A comprehensive system: Vol. I. Basic foundations and principles of interpretation (1st ed.). New York : John Wiley & Sons.

26.

Exner, JE, Jr. (1993). The Rorschach: A comprehensive system: Vol. I. Basic foundations and principles of interpretation (3ed ed.). New York : John Wiley & Sons.

27.

Exner, JE, Jr. (2003). The Rorschach: A comprehensive system: Vol. I. Basic foundations and principles of interpretation (4th ed.). New York : John Wiley & Sons.

28.

Greene, R. L. (2000). The MMPI-2: An interpretive manual. Boston : Allyn & Bacon.

29.

Hunsley, J., & Bailey, J. M. (1999). The clinical utility of the Rorschach: Unfulfilled promises and an uncertain future. Psychological Assessment, 11(3), 266.

30.

Keyes, M. D. (2003). Assessing schizophrenia with the MMPI-2. Pacific Graduate School of Psychology.

31.

Lerner, P. M. (1998). Schachtel and experiential Rorschach assessment. Journal of personality assessment, 71(2), 182-188.

32.

Magaro, P. A. (1981). The paranoid and the schizophrenic: The case for distinct cognitive style. Schizophrenia Bulletin, 7(4), 632.

33.

Meyer, G. J. (2000). On the science of Rorschach research. Journal of Personality Assessment, 75(1), 46-81.

34.

Munley, P. H., Busby, R. M., & Jaynes, G. (1997). MMPI—2 findings in schizophrenia and depression. Psychological assessment, 9(4), 508.

35.

Nichols, D. S. (2011). Essentials of MMPI-2assessment. New York : John Wiley & Sons.

36.

Parmer, J. C. (1991). Bulimia and object relations:MMPI and Rorschach variables. Journal of personality assessment, 56(2), 266-276.

37.

Pensa, R., Dorfman, W. I., & Gold, S. N. (1996). Detection of malingered psychosis with the MMPI-2. Psychotherapy in private practice, 14(4), 47-63.

38.

Rapaport, D., & Schafer, R. (1945). The Rorschach test: a clinical evaluation. Chicago : Bulletin of the Menninger Clinic.

39.

Rapaport, D., Gill, M., & Schafer, R. (1968). Diagnostic psychological testing. New York :International Universities Press.

40.

Ritsher, J. B. (2004). Association of Rorschach and MMPI psychosis indicators and schizophrenia spectrum diagnoses in a Russian clinical sample. Journal of personality assessment, 83(1), 46-63.

41.

Ritzler, B., Zambianco, D., Harder, D., & Kaskey, M. (1980). Psychotic patterns of the concept of the object on the Rorschach test. Journal of Abnormal Psychology, 89(1), 46.

42.

Rosenbaum, B., Andersen, P. B., Knudsen, P. B., & Lorentzen, P. (2012). Rorschach Inkblot Method data at baseline and after 2 years treatment of consecutively admitted patients with first-episode schizophrenia. Nordic journal of psychiatry, 66(2), 79-85.

43.

Spitzer, R. L. (2001). Values and assumptions in the development of DSM-III and DSM-III-R: An insider's perspective and a belated response to Sadler, Hulgus, and Agich's “On values in recent American psychiatric classification". The Journal of nervous and mental disease, 189(6), 351-359.

44.

Varghese, F. (2003). Symptoms in the mind: an introduction to descriptive psychopathology. Australian and New Zealand Journal of Psychiatry, 37(4), 496-497.

45.

Weiner, I. B. (1961). Three Rorschach scores indicative of schizophrenia. Journal of consulting psychology, 25(5), 436.

46.

Wetzler, S., Khadivi, A., & Moser, R. K. (1998). The use of the MMPI-2 for the assessment of depressive and psychotic disorders. Assessment, 5(3), 249-261.

47.

Wood, J. M., Lilienfeld, S. O., Garb, H. N., & Nezworski, M. T. (2000). The Rorschach test in clinical diagnosis: A critical review, with a backward look at Garfield(1947). Journal of Clinical Psychology, 56(3), 395-430.

The Korean Journal of Health Psychology